MODULATION OF HLA-DR ANTIGENS EXPRESSION IN HUMAN MYELOID LEUKAEMIA CELLS BY CYTARABINE AND 5-AZA-2'-DEOXYCYTIDINE
β Scribed by Pinto, Antonio; Maio, Michele; Attadia, Vincenza; Zappacosta, Serafino; Cimino, Renato
- Book ID
- 121964191
- Publisher
- The Lancet
- Year
- 1984
- Tongue
- English
- Weight
- 434 KB
- Volume
- 324
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cell surface expression of HLA class I/peptide complexes on tumor cells is a key step in the generation of T-cell-based immune responses. Several genetic defects underlying the lack of HLA class I expression have been characterized. Here we describe another molecular mechanism that accounts for the
## Abstract The DNA methylation inhibitor 5βAzaβ2β²βdeoxycytidine (5βAzaβCdR) has significant therapeutic value for the treatment of patients with myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). The demethylating effect of 5βAzaβCdR has been well char